Related Experiment Video
Updated: Jun 2, 2026

10:46
Production of Human Norovirus Protruding Domains in E. coli for X-ray Crystallography
Published on: April 19, 2016
Targeting norovirus infection-multivalent entry inhibitor design based on NMR experiments
Christoph Rademacher1, Julie Guiard, Pavel I Kitov
1Center of Structural and Cell Biology in Medicine, Institute of Chemistry, University of Luebeck, Ratzeburger Allee 160, 23562 Luebeck, Germany.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|May 14, 2011
Summary
Researchers identified compounds that block norovirus attachment to host cells using NMR binding studies. This strategy led to potent multivalent inhibitors, offering new therapeutic avenues for norovirus infections.
Area of Science:
- Virology
- Biochemistry
- Medicinal Chemistry
Background:
- Noroviruses utilize histo blood group antigens (HBGAs) for host cell attachment.
- Compounds inhibiting this interaction are valuable for therapeutic and diagnostic applications.
Purpose of the Study:
- To identify and characterize compounds that bind to the norovirus HBGA binding site.
- To develop potent multivalent entry inhibitors against norovirus infections.
Main Methods:
- Nuclear Magnetic Resonance (NMR) binding studies, including Saturation Transfer Difference (STD) NMR, spin-lock filtered NMR, and interligand NOE (ILOE) experiments.
- Utilized virus-like particles (VLPs) to identify ligands binding to the HBGA site.
- Synthesized multivalent prototype entry-inhibitors based on identified compounds.
Main Results:
- NMR studies successfully identified and differentiated binding sites for HBGA ligands and complementary ligands.
- Two multivalent prototype entry-inhibitors were synthesized and tested.
- Surface plasmon resonance assays demonstrated significant avidity gains (1000 to one million fold) compared to univalent ligands.
Conclusions:
- NMR-based screening is effective for identifying compounds that bind to the norovirus HBGA binding site.
- The developed multivalent inhibitors show greatly enhanced binding avidity.
- This strategy facilitates the rational design of potent norovirus entry inhibitors for therapeutic development.
Related Concept Videos
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...

